Cholecystolithiasis

disease
On this page

Summary

Cholecystolithiasis (MONDO:0006698) is a disease and 41 clinical trials. Top therapeutic interventions include ursodiol, droperidol, and esketamine. A subtype of gallbladder disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Clinical trials: 41

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical namecholecystolithiasis
Mondo IDMONDO:0006698
EFOEFO:1000864
MeSHD041761
DOIDDOID:11151
UMLSC0947622
MedGen215268
MedDRA10049890
Is cancer (heuristic)no

Disease family

This is a subtype of gallbladder disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › digestive system disorderhepatobiliary disordergallbladder disordercholecystolithiasis

Related subtypes (10): cholesterolosis of gallbladder, cholecystitis, occlusion of gallbladder, hydrops of gallbladder, biliary dyskinesia, gallbladder neoplasm, polyp of gallbladder, Rokitansky-Aschoff sinuses of the gallbladder, hereditary gallbladder disorder, gallbladder duplication

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 41.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified34
PHASE46
PHASE2/PHASE31

Top trials by phase / activity

NCTPhaseStatusTitle
NCT00161083PHASE4COMPLETEDUDCA for Symptomatic Gallstone Disease
NCT00209885PHASE4UNKNOWNOptimal Multimodal Analgesia in Laparoscopic Cholecystectomy
NCT00562900PHASE4COMPLETEDRobotic Assisted Versus Laparoscopic Cholecystectomy - Outcome and Cost Analyses of a Case-Matched Control Study
NCT01199406PHASE4COMPLETEDPain Reduction After Cholecystectomy
NCT02114437PHASE4UNKNOWNClosed-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy
NCT02116985PHASE4COMPLETEDDual-Loop Target Controlled Infusion in Laparoscopic Cholecystectomy (DLTCI)
NCT00370344PHASE2/PHASE3COMPLETEDSmall-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease
NCT03812718Not specifiedRECRUITINGComparison of Anaesthesia Requirement for Ventilation With Endotracheal Tube Versus Proseal Laryngeal Mask Airway
NCT06045546Not specifiedACTIVE_NOT_RECRUITINGA (5-5-5-8) Technique for Laparoscopic Cholecystectomy
NCT07002619Not specifiedRECRUITINGChOlanGiography Performed Routinely Versus Selectively During Cholecystectomy: A NAtional Registry-based Randomized Controlled Trial
NCT07245108Not specifiedRECRUITINGThe Pro-Chol Study
NCT00940264Not specifiedCOMPLETEDLaparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection.
NCT00974194Not specifiedCOMPLETEDSafety and Cost-effectiveness Study of Single Port Laparoscopic Cholecystectomies
NCT01047085Not specifiedCOMPLETEDDoes Cholecystectomy Increase the Esophageal Alkaline Reflux? Evaluation by Impedance-pH Technique
NCT01056250Not specifiedCOMPLETEDSILS Cholecystectomy: Cholangiography of the Biliary Tract
NCT01289379Not specifiedCOMPLETEDThe Effect of High Frequency Jet Ventilation (HFJV)During Laparoscopic Operations
NCT01552421Not specifiedTERMINATEDThe Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative Course
NCT01553331Not specifiedCOMPLETEDDay Case Laparoscopic Cholecystectomy: Fundus First With Ultrasonic Dissection or Conventional Diathermy Hook
NCT01615549Not specifiedUNKNOWNEfficacy of Proficiency-based Versus Free Laparoscopic Training in Cholecystectomy on a Virtual Reality Simulator
NCT01667848Not specifiedCOMPLETEDWarmed, Humidified Carbon Dioxide Insufflation vs Standard Carbon Dioxide in Laparoscopic Cholecystectomy
NCT01740973Not specifiedCOMPLETEDRisk of Umbilical Trocar-site Hernia After SILC Cholecystectomy Versus Conventional Cholecystectomy
NCT01824186Not specifiedCOMPLETEDTrial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy
NCT02357589Not specifiedCOMPLETED3D vs 2D HD Laparoscopy in Cholecystectomy
NCT02554097Not specifiedUNKNOWNChinese Registry Study on Treatment of Cholecysto-Choledocholithiasis
NCT02558556Not specifiedUNKNOWNFALCON: a Multicenter Randomized Controlled Trial
NCT02752698Not specifiedUNKNOWNDomestic Surgical Robot Clinical Study
NCT03154164Not specifiedCOMPLETEDStudy on the Learning Curve for Fundus First With Ultrasonic Tissue Coagulation in Elective Cholecystectomy
NCT03909360Not specifiedUNKNOWNDrainage or Not for Laparoscopic Cholecystetomy
NCT04052633Not specifiedCOMPLETEDSuccess of Intraoperative Cholangiography
NCT04142203Not specifiedCOMPLETEDImplementation of 23 Hour Surgery Model in a Tertiary Hospital
NCT04737642Not specifiedCOMPLETEDFeasibility and Safety of Bile Duct Clearance by Transcystic Sphincter of Oddi Balloon Dilatation
NCT04922528Not specifiedUNKNOWNVisualization of the Extrahepatic biliaRy Tree Trial
NCT05280860Not specifiedUNKNOWNEffect of Bilateral RSB on Postoperative Delirium in Elderly Patients Undergoing Laparoendoscopic Single-site Surgery
NCT05723224Not specifiedUNKNOWNElective Endoscopic Gallbladder Treatment: Pilot Study
NCT05827445Not specifiedCOMPLETEDCutaneous Sensory Block Area of the Laparoscopic Assisted Transversus Abdominis Plane Block
NCT05962853Not specifiedCOMPLETEDEffect of TENS on Patient Outcomes After Laparoscopic Cholecystectomy
NCT06035302Not specifiedUNKNOWNMadany Closure: A Novel Technique for Fascial Closure in Laparoscopic Surgery
NCT06036303Not specifiedUNKNOWNNasr Fascial Closure: A Novel Device for Fascial Closure in Laparoscopic Surgery
NCT06672991Not specifiedCOMPLETEDERCP and LC for Cholecystocholedocholithiasis in Children: Should It Be Accomplished in One or Repeated Hospitalization?
NCT06676241Not specifiedCOMPLETEDOne-stage and Delayed Laparoscopic Cholecystectomy After Endoscopic Retrograde Cholangiopancreatography with Endoscopic Sphincterotomy in Cholecystocholedocholithiasis

Drugs tested across these trials (top 30)

MoleculeMax phaseTrials referencing
URSODIOL42
DROPERIDOL41
ESKETAMINE41
GABAPENTIN41
LEVOBUPIVACAINE41
LIDOCAINE41
CHEMBL540958301